Literature DB >> 7862941

Sedative, memory, and performance effects of hypnotics.

T Roehrs1, L Merlotti, F Zorick, T Roth.   

Abstract

The sedative, amnestic, and performance disruptive effects of benzodiazepine (Bz) receptor selective and non-selective hypnotics were studied in 23 healthy, normal subjects, aged 26.8 +/- 1.0 years. Triazolam (0.25 and 0.50 mg), zolpidem (10 and 20 mg) and placebo were administered, double-blind, at bedtime in a repeated measures design. During an awakening 90 min later (at approximate peak concentration of each drug) a 30-min performance battery which included memory, vigilance, and psychomotor tasks was completed. Each drug and dose impaired memory (both immediate and delayed), vigilance, and psychomotor performance relative to placebo. Among active drugs impairment was greatest with zolpidem 20 mg, next triazolam 0.50 mg, then zolpidem 10 mg, and finally triazolam 0.25 mg. Next morning delayed recall was also impaired by all drugs and doses (i.e. anterograde amnesia). The amnestic and performance-disruptive effects paralleled the relative hypnotic effects of the drugs and doses. No receptor selectivity in these pharmacodynamic effects was observed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862941     DOI: 10.1007/bf02245054

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

Review 2.  Measurement and interpretation of changes in memory in response to drug treatments.

Authors:  H Weingartner; M Eckardt; S Molchan; T Sunderland; O Wolkowitz
Journal:  Psychopharmacol Bull       Date:  1992

Review 3.  Hypnotics and behavior.

Authors:  T Roth; T A Roehrs; E J Stepanski; L D Rosenthal
Journal:  Am J Med       Date:  1990-03-02       Impact factor: 4.965

4.  Effects of benzodiazepines on sleep and wakefulness.

Authors:  T Roth; F Zorick; J Sicklesteel; E Stepanski
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

5.  Effects of hypnotics on memory.

Authors:  T Roehrs; F J Zorick; J M Sicklesteel; R M Wittig; K M Hartse; T Roth
Journal:  J Clin Psychopharmacol       Date:  1983-10       Impact factor: 3.153

6.  Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives.

Authors:  H V Curran; W Schiwy; M Lader
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Benzodiazepines and memory.

Authors:  T Roth; T Roehrs; R Wittig; F Zorick
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

Review 8.  Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors.

Authors:  R F Squires; D I Benson; C Braestrup; J Coupet; C A Klepner; V Myers; B Beer
Journal:  Pharmacol Biochem Behav       Date:  1979-05       Impact factor: 3.533

Review 9.  The amnesic action of benzodiazepines in man.

Authors:  R G Lister
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

10.  The dose effects of zolpidem on the sleep of healthy normals.

Authors:  L Merlotti; T Roehrs; G Koshorek; F Zorick; J Lamphere; T Roth
Journal:  J Clin Psychopharmacol       Date:  1989-02       Impact factor: 3.153

  10 in total
  22 in total

Review 1.  Hypnotics: an update.

Authors:  Timothy Roehrs; Thomas Roth
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

2.  Pharmacological Treatment of Insomnia.

Authors:  Janette D Lie; Kristie N Tu; Diana D Shen; Bonnie M Wong
Journal:  P T       Date:  2015-11

3.  Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.

Authors:  Timothy A Roehrs; S Randall; E Harris; R Maan; T Roth
Journal:  J Psychopharmacol       Date:  2011-10-16       Impact factor: 4.153

4.  Comparative pharmacodynamics of Ro 41-3696, a new hypnotic, and zolpidem after night-time administration to healthy subjects.

Authors:  J Dingemanse; M Bury; J Bock; P Joubert
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

Review 5.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

Review 6.  Insomnia pharmacotherapy.

Authors:  Timothy Roehrs; Thomas Roth
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

7.  Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.

Authors:  Geert Mayer; Sherry Wang-Weigand; Barbara Roth-Schechter; Reiner Lehmann; Corinne Staner; Markku Partinen
Journal:  Sleep       Date:  2009-03       Impact factor: 5.849

Review 8.  Hypnosedative-induced complex behaviours : incidence, mechanisms and management.

Authors:  Christian R Dolder; Michael H Nelson
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 9.  Pharmacotherapy of insomnia: practice and prospects.

Authors:  J Dingemanse
Journal:  Pharm World Sci       Date:  1995-05-26

10.  Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.

Authors:  Thomas Roth; David Mayleben; Bruce C Corser; Nikhilesh N Singh
Journal:  Hum Psychopharmacol       Date:  2008-01       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.